Loading clinical trials...
Loading clinical trials...
A Phase 2b, Randomized, Double-Blind,Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery
Conditions
Interventions
ABT-719
Placebo
Locations
41
United States
Site Reference ID/Investigator# 83739
Danbury, Connecticut, United States
Site Reference ID/Investigator# 87720
Gainesville, Florida, United States
Site Reference ID/Investigator# 83746
Jacksonville, Florida, United States
Site Reference ID/Investigator# 83733
Jacksonville, Florida, United States
Site Reference ID/Investigator# 89178
Tampa, Florida, United States
Site Reference ID/Investigator# 87693
Atlanta, Georgia, United States
Start Date
February 1, 2013
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
July 7, 2021
NCT05806645
NCT07472426
NCT07447791
NCT07106151
NCT07418242
NCT05879432
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions